Bluejay Diagnostics (BJDX) Consolidated Net Income (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Consolidated Net Income of -$2.0 million for Q1 2026, down 41.22% sequentially from -$1.4 million in Q4 2025, and down 5.79% YoY from -$2.1 million in Q1 2025.
Bluejay Diagnostics (BJDX) Consolidated Net Income (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Consolidated Net Income for 7 years, with the latest figure at -$2.0 million in Q1 2026.
- Quarterly Consolidated Net Income fell 5.79% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.0 million (up 12.69% YoY) and the FY2025 annual result came in at -$18.9 million, down 11.06% from the prior year.
- Consolidated Net Income fell to -$2.0 million in Q1 2026 per BJDX's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at -$1.4 million in Q4 2025 and troughed at -$3.0 million in Q2 2023.
- A 5-year average of -$2.2 million and a median of -$2.1 million in 2024 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2022 and 2024: Consolidated Net Income slumped 791.77% in 2022, then jumped 36.48% in 2024.
- Over 5 years, Consolidated Net Income stood at -$2.5 million in 2022, then climbed by 2.39% to -$2.4 million in 2023, then rose by 12.15% to -$2.1 million in 2024, then surged by 33.02% to -$1.4 million in 2025, then plunged by 41.22% to -$2.0 million in 2026.
- According to Business Quant data, Consolidated Net Income over the past three periods registered -$2.0 million, -$1.4 million, and -$1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Bluejay Diagnostics | 1.94 Mn | 1.94 Mn | - | -2.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.40 Mn |
| Mar 31, 2026 | -2.02 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Sep 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -1.97 Mn |
| Mar 31, 2025 | -1.91 Mn |
| Dec 31, 2024 | -2.14 Mn |
| Sep 30, 2024 | -1.49 Mn |
| Jun 30, 2024 | -2.51 Mn |
| Mar 31, 2024 | -2.44 Mn |
| Dec 31, 2023 | -2.43 Mn |
| Sep 30, 2023 | -2.35 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Mar 31, 2023 | -2.72 Mn |
| Dec 31, 2022 | -2.49 Mn |
| Sep 30, 2022 | -2.91 Mn |
| Jun 30, 2022 | -2.13 Mn |
| Mar 31, 2022 | -2.10 Mn |
| Dec 31, 2021 | -1.34 Mn |
| Sep 30, 2021 | -1.69 Mn |